Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)

Italy flag Italy · Delayed Price · Currency is EUR
499.20
-5.60 (-1.11%)
At close: Dec 4, 2025
81.00%
Market Cap 11.42B
Revenue (ttm) 631.25M
Net Income (ttm) -246.42M
Shares Out n/a
EPS (ttm) -11.11
PE Ratio n/a
Forward PE 128.25
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 0
Open n/a
Previous Close 504.80
Day's Range n/a
52-Week Range 237.50 - 518.20
Beta n/a
RSI 64.14
Earnings Date Feb 25, 2026

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania. [Read more]

Industry Pharmaceutical Preparations
CEO William Sibold
Employees 528
Stock Exchange Borsa Italiana
Ticker Symbol 1MDGL
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.